Dormant Company Accounts - PROTON THERAPY USA LIMITED

Dormant Company Accounts - PROTON THERAPY USA LIMITED


Companies House true 2020-07-01 2021-06-30 false 07964052 uk-bus:Director1 2020-07-01 2021-06-30 07964052 uk-bus:Director2 2020-07-01 2021-06-30 07964052 2020-07-01 2021-06-30 07964052 2021-06-30 07964052 uk-bus:EntityHasNeverTraded 2020-07-01 2021-06-30 07964052 uk-bus:FRS102 2020-07-01 2021-06-30 07964052 uk-bus:FullAccounts 2020-07-01 2021-06-30 07964052 uk-bus:AuditExempt-NoAccountantsReport 2020-07-01 2021-06-30 07964052 2020-06-30 07964052 uk-bus:OrdinaryShareClass1 2020-07-01 2021-06-30 07964052 uk-bus:OrdinaryShareClass2 2020-07-01 2021-06-30 07964052 uk-bus:OrdinaryShareClass3 2020-07-01 2021-06-30 07964052 uk-bus:PreferenceShareClass1 2020-07-01 2021-06-30 07964052 uk-bus:PreferenceShareClass2 2020-07-01 2021-06-30 07964052 uk-bus:PreferenceShareClass3 2020-07-01 2021-06-30 07964052 uk-core:ShareCapitalPreferenceShares 2021-06-30 07964052 uk-core:ShareCapitalPreferenceShares 2020-06-30 iso4217:GBP xbrli:shares

Registered Number 07964052

PROTON THERAPY USA LIMITED

Dormant Accounts

30 June 2021

PROTON THERAPY USA LIMITED Registered Number 07964052

Balance Sheet as at 30 June 2021

2021 2020
£ £
Current assets
Cash at bank and in hand
1
1
Net assets
1
1
Issued share capital
1 Ordinary Share of £ 1 each 1 1
Total Shareholder funds
1
1

STATEMENTS

  1. For the year ending 30 June 2021 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 14 February 2022

And signed on their behalf by:
Michael SINCLAIR, Director